On Nov 2, 2021 Cambridge Epigenetix closed a Series D round and raised $88,000,000 from Ahren Innovation Capital, GV, New Science Ventures, Sequoia Capital, Temasek […]
Venture Round – Shoreline Biosciences
On Nov 2, 2021 Shoreline Biosciences closed a Venture – Series Unknown round and raised $140,000,000 from Ally Bridge Group, BeiGene, Boxer Capital, BVF Partners, […]
Series D – Antiva Biosciences
On Nov 2, 2021 Antiva Biosciences closed a Series D round and raised $31,000,000 from Adjuvant Capital, Alexandria Venture Investments, Avestria Ventures, Brace Pharma, Canaan […]
Series D – Cambridge Epigenetix
On Nov 2, 2021 Cambridge Epigenetix closed a Series D round and raised $88,000,000 from Ahren Innovation Capital, GV, New Science Ventures, Sequoia Capital, Temasek […]
Series B – Violet Defense
On Nov 2, 2021 Violet Defense closed a Series B round and raised $20,000,000 from Katalyst Securities, Kirenaga Partners, featuring lead investors Katalyst Securities, Kirenaga […]
Venture Round – Shoreline Biosciences
On Nov 2, 2021 Shoreline Biosciences closed a Venture – Series Unknown round and raised $140,000,000 from Ally Bridge Group, BeiGene, Boxer Capital, BVF Partners, […]
SimplePay Health acquired by Coupe Health
Nov 1, 2021 Coupe Health has entered into an agreement to acquire SimplePay Health . Coupe Health based at Eagan, Minnesota, United States. ” Health […]
Post-IPO Equity – Valneva
On Nov 1, 2021 Valneva closed a Post-IPO Equity round and raised €88,000,000 from investors, featuring lead investors . About the company: Valneva is located […]
Post-IPO Equity – Valneva
On Nov 1, 2021 Valneva closed a Post-IPO Equity round and raised €88,000,000 from investors, featuring lead investors . About the company: Valneva is located […]
Seed Round – Ombre
On Nov 1, 2021 Ombre closed a Seed round and raised $3,000,000 from Joyance Partners, PivotNorth Capital, Shanda Group, TMV, Unilever Ventures, Unpopular Ventures, featuring […]
